10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001558370-17-008851`
Period End Date	20170930
Filing Date	20171113
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	bgne-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 82 Cash Flow Statement 84 Comprehensive Income 22

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.87M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$87.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$208.51M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$85.53M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$548.92M	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	589.77M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	515.83M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$280.66M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$10.52M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	589.77M	shares	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	515.83M	shares	Point-in-time
Unbilled receivable	`UnbilledReceivablesCurrent`	$170.95M	USD	Point-in-time
Inventories	`InventoryNet`	$5.71M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.22M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$17.71M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$374.40M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$962.33M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$55.32M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$25.98M	USD	Point-in-time
Land use right, net	`LandUseRightNet`	$12.25M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$7.44M	USD	Point-in-time
Goodwill	`Goodwill`	$1.98M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$7.68M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$768.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.67M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.05M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$86.73M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$31.41M	USD	Point-in-time
Total assets	`Assets`	$405.81M	USD	Point-in-time
Total assets	`Assets`	$1.05B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.96M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$35.17M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesAccountsPayableOtherAndOtherLiabilitiesCurrent`	$46.99M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesAccountsPayableOtherAndOtherLiabilitiesCurrent`	$22.30M	USD	Point-in-time
Deferred revenue, current portion	`DeferredRevenueCurrent`	$9.13M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$2.85M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$804.00K	USD	Point-in-time
Current portion of long-term bank loan	`LongTermDebtCurrent`	$9.02M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$35.06M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$103.16M	USD	Point-in-time
Long-term bank loan	`LongTermLineOfCredit`	$17.28M	USD	Point-in-time
Long-term bank loan	`LongTermLineOfCredit`	$9.02M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$140.31M	USD	Point-in-time
Deferred revenue, non-current portion	`DeferredRevenueNoncurrent`	$29.48M	USD	Point-in-time
Deferred tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$1.86M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$744.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$564.00K	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$181.41M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$17.85M	USD	Point-in-time
Total liabilities	`Liabilities`	$284.57M	USD	Point-in-time
Total liabilities	`Liabilities`	$52.91M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares (par value of US$0.0001 per share; 9,500,000,000 shares authorized; 589,772,330 shares issued and outstanding as of September 30, 2017 (December 31, 2016: 9,500,000,000 shares authorized; 515,833,609 shares issued and outstanding))	`CommonStockValue`	$52.00K	USD	Point-in-time
Ordinary shares (par value of US$0.0001 per share; 9,500,000,000 shares authorized; 589,772,330 shares issued and outstanding as of September 30, 2017 (December 31, 2016: 9,500,000,000 shares authorized; 515,833,609 shares issued and outstanding))	`CommonStockValue`	$59.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$981.24M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$591.21M	USD	Point-in-time
Accumulated other comprehensive income /(loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-946.00K	USD	Point-in-time
Accumulated other comprehensive income /(loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$38.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-237.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-231.19M	USD	Point-in-time
Total BeiGene, Ltd. shareholders' equity	`StockholdersEquity`	$352.91M	USD	Point-in-time
Total BeiGene, Ltd. shareholders' equity	`StockholdersEquity`	$750.14M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$14.35M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$764.49M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$352.91M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$1.05B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$405.81M	USD	Point-in-time

Income Statement 82 line items

Line Item	Tag	Value	Unit	Period
Product revenue, net	`SalesRevenueGoodsNet`	$8.82M	USD	3 Qtrs
Product revenue, net	`SalesRevenueGoodsNet`	$8.82M	USD	1 Quarter
Collaboration revenue	`CollaborationRevenue`	$211.39M	USD	3 Qtrs
Collaboration revenue	`CollaborationRevenue`	$1.07M	USD	3 Qtrs
Collaboration revenue	`CollaborationRevenue`	$211.39M	USD	1 Quarter
Total revenue	`Revenues`	$220.21M	USD	3 Qtrs
Total revenue	`Revenues`	$220.21M	USD	1 Quarter
Total revenue	`Revenues`	$1.07M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsSold`	$1.94M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsSold`	$1.94M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$177.68M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$69.10M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$87.66M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$30.11M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$4.72M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$15.64M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$35.19M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$11.76M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$63.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$63.00K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$34.83M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$105.31M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$214.87M	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$80.86M	USD	3 Qtrs
Income /(loss) from operations	`OperatingIncomeLoss`	$-79.79M	USD	3 Qtrs
Income /(loss) from operations	`OperatingIncomeLoss`	$-34.83M	USD	1 Quarter
Income /(loss) from operations	`OperatingIncomeLoss`	$5.34M	USD	3 Qtrs
Income /(loss) from operations	`OperatingIncomeLoss`	$114.91M	USD	1 Quarter
Interest (expense)/income, net	`InterestIncomeExpenseNet`	$-3.58M	USD	3 Qtrs
Interest (expense)/income, net	`InterestIncomeExpenseNet`	$-75.00K	USD	1 Quarter
Interest (expense)/income, net	`InterestIncomeExpenseNet`	$336.00K	USD	3 Qtrs
Interest (expense)/income, net	`InterestIncomeExpenseNet`	$-1.78M	USD	1 Quarter
Changes in fair value of financial instruments	`GainsLossesFromDecreaseIncreaseInFairValueOfFinancialInstruments`	$-1.51M	USD	3 Qtrs
(Loss)/gain on sale of available-for-sale securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$-137.00K	USD	1 Quarter
(Loss)/gain on sale of available-for-sale securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$10.00K	USD	3 Qtrs
(Loss)/gain on sale of available-for-sale securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$-1.08M	USD	3 Qtrs
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$1.53M	USD	3 Qtrs
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$732.00K	USD	3 Qtrs
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$1.10M	USD	1 Quarter
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$-327.00K	USD	1 Quarter
Income/(loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-35.37M	USD	1 Quarter
Income/(loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$114.22M	USD	1 Quarter
Income/(loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.30M	USD	3 Qtrs
Income/(loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-81.31M	USD	3 Qtrs
Income tax benefit /(expense)	`IncomeTaxExpenseBenefit`	$306.00K	USD	3 Qtrs
Income tax benefit /(expense)	`IncomeTaxExpenseBenefit`	$-3.06M	USD	1 Quarter
Income tax benefit /(expense)	`IncomeTaxExpenseBenefit`	$127.00K	USD	1 Quarter
Income tax benefit /(expense)	`IncomeTaxExpenseBenefit`	$-2.68M	USD	3 Qtrs
Net income /(loss)	`ProfitLoss`	$-81.62M	USD	3 Qtrs
Net income /(loss)	`ProfitLoss`	$5.98M	USD	3 Qtrs
Net income /(loss)	`ProfitLoss`	$-35.49M	USD	1 Quarter
Net income /(loss)	`ProfitLoss`	$117.28M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-237.00K	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-102.00K	USD	1 Quarter
Net income /(loss) attributable to BeiGene, Ltd.	`NetIncomeLoss`	$117.39M	USD	1 Quarter
Net income /(loss) attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-35.49M	USD	1 Quarter
Net income /(loss) attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-81.62M	USD	3 Qtrs
Net income /(loss) attributable to BeiGene, Ltd.	`NetIncomeLoss`	$6.22M	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.01	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.08	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.21	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.21	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.20	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.21	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.08	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.01	USD	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	527.33M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	547.55M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	383.47M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	428.14M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	600.61M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	428.14M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	383.47M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	561.24M	shares	3 Qtrs
Basic (in dollars per ADS) (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$0.15	USD	3 Qtrs
Basic (in dollars per ADS) (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$2.79	USD	1 Quarter
Basic (in dollars per ADS) (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-1.08	USD	1 Quarter
Basic (in dollars per ADS) (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-2.77	USD	3 Qtrs
Diluted (in dollars per ADS) (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$0.14	USD	3 Qtrs
Diluted (in dollars per ADS) (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-2.77	USD	3 Qtrs
Diluted (in dollars per ADS) (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$2.54	USD	1 Quarter
Diluted (in dollars per ADS) (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-1.08	USD	1 Quarter

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Net income /(loss)	`ProfitLoss`	$-81.62M	USD	3 Qtrs
Net income /(loss)	`ProfitLoss`	$5.98M	USD	3 Qtrs
Net income /(loss)	`ProfitLoss`	$-35.49M	USD	1 Quarter
Net income /(loss)	`ProfitLoss`	$117.28M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.70M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.44M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$6.68M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$26.40M	USD	3 Qtrs
Changes in fair value of financial instruments	`GainsLossesFromDecreaseIncreaseInFairValueOfFinancialInstruments`	$-1.51M	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-85.00K	USD	3 Qtrs
Non-cash interest expense	`InterestExpenseOperatingActivities`	$118.00K	USD	3 Qtrs
Non-cash interest expense	`InterestExpenseOperatingActivities`	$4.80M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-5.87M	USD	3 Qtrs
Other non-cash expenses	`OtherNoncashIncomeExpense`	$-1.08M	USD	3 Qtrs
Other non-cash expenses	`OtherNoncashIncomeExpense`	$10.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$10.52M	USD	3 Qtrs
Unbilled receivable	`IncreaseDecreaseInUnbilledReceivables`	$170.95M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$5.71M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.18M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$10.97M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$1.28M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$635.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.84M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$21.42M	USD	3 Qtrs
Advances from customers	`IncreaseDecreaseInCustomerAdvances`	$-1.07M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$22.37M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$13.36M	USD	3 Qtrs
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$294.00K	USD	3 Qtrs
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$1.12M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$38.61M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$180.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$142.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-81.00M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-63.37M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.44M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$27.44M	USD	3 Qtrs
Payment for the acquisition of land use right	`PaymentsToLandUseRights`	$12.35M	USD	3 Qtrs
Cash acquired in business combination, net of cash paid	`CashAcquiredFromAcquisitionNetOfCashPaid`	$19.92M	USD	3 Qtrs
Purchase of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$194.00M	USD	3 Qtrs
Purchase of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$464.06M	USD	3 Qtrs
Proceeds from sale or maturity of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$158.31M	USD	3 Qtrs
Proceeds from sale or maturity of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$245.93M	USD	3 Qtrs
Investment in time deposits	`PaymentsToAcquireOtherInvestmentsTimeDeposits`	$50.06M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-51.13M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-288.08M	USD	3 Qtrs
Proceeds from issuance of ordinary shares, net of underwriter discount	`ProceedsFromIssuancePublicOffering`	$189.19M	USD	3 Qtrs
Proceeds from issuance of ordinary shares, net of underwriter discount	`ProceedsFromIssuancePublicOffering`	$169.41M	USD	3 Qtrs
Payment of initial public offering cost	`PaymentsOfStockIssuanceCosts`	$674.00K	USD	3 Qtrs
Payment of initial public offering cost	`PaymentsOfStockIssuanceCosts`	$1.48M	USD	3 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	$149.93M	USD	3 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$12.16M	USD	3 Qtrs
Proceeds from short-term loan	`ProceedsFromShortTermDebt`	$2.47M	USD	3 Qtrs
Repayment of short-term loan	`RepaymentsOfShortTermDebt`	$2.47M	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$14.53M	USD	3 Qtrs
Proceeds from shareholder loan	`ProceedsFromRelatedPartyDebt`	$132.76M	USD	3 Qtrs
Proceeds from exercise of warrants and options	`ProceedsFromWarrantExercisesAndStockOptionsExercised`	$2.12M	USD	3 Qtrs
Proceeds from option exercises	`ProceedsFromStockOptionsExercised`	$1.58M	USD	3 Qtrs
Proceeds from option exercises	`ProceedsFromStockOptionsExercised`	$3.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$182.21M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$487.31M	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-45.00K	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$2.76M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$67.66M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$121.00M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$17.87M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$87.51M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$208.51M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$85.53M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$17.87M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$87.51M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$208.51M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$85.53M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$25.00K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.43M	USD	3 Qtrs
Interest expense paid	`InterestPaidNet`	$940.00K	USD	3 Qtrs
Interest expense paid	`InterestPaidNet`	$510.00K	USD	3 Qtrs
Discount provided on sale of ordinary shares for business combination	`DiscountProvidedForIssuanceOfOrdinaryShares`	$23.61M	USD	3 Qtrs
Conversion of Senior Promissory Note	`DebtConversionConvertedInstrumentAmount1`	$14.69M	USD	3 Qtrs
Conversion of deferred rental	`ConversionOfDeferredRental`	$980.00K	USD	3 Qtrs
Conversion of convertible preferred shares	`ConversionOfStockAmountIssued1`	$176.08M	USD	3 Qtrs
Exercise of warrants and options	`ConversionOfWarrantAndOptionLiabilities`	$3.69M	USD	3 Qtrs
Initial public offering costs accrued in accrued expenses and other payables	`InitialPublicOfferingCostsAccruedForInAccruedExpensesAndOtherPayables`	$166.00K	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$319.00K	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$1.48M	USD	3 Qtrs

Comprehensive Income 22 line items

Line Item	Tag	Value	Unit	Period
Net income /(loss)	`ProfitLoss`	$-81.62M	USD	3 Qtrs
Net income /(loss)	`ProfitLoss`	$5.98M	USD	3 Qtrs
Net income /(loss)	`ProfitLoss`	$-35.49M	USD	1 Quarter
Net income /(loss)	`ProfitLoss`	$117.28M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$341.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$985.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-13.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$377.00K	USD	1 Quarter
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$121.00K	USD	1 Quarter
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$58.00K	USD	3 Qtrs
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$51.00K	USD	1 Quarter
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$857.00K	USD	3 Qtrs
Comprehensive income /(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$117.68M	USD	1 Quarter
Comprehensive income /(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.02M	USD	3 Qtrs
Comprehensive income /(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-35.00M	USD	1 Quarter
Comprehensive income /(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-80.78M	USD	3 Qtrs
Less: Comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-70.00K	USD	1 Quarter
Less: Comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-178.00K	USD	3 Qtrs
Comprehensive income /(loss) attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-35.00M	USD	1 Quarter
Comprehensive income /(loss) attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$117.75M	USD	1 Quarter
Comprehensive income /(loss) attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-80.78M	USD	3 Qtrs
Comprehensive income /(loss) attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$7.20M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.